Sublingual Semaglutide

Sublingual semaglutide is a compounded, prescription-only medication designed to be placed under the tongue rather than injected. Semaglutide acts on GLP-1 pathways involved in appetite, food intake, and blood sugar regulation. When prescribed as part of a medically supervised weight-management program, it may help eligible patients manage appetite and support sustainable nutrition and lifestyle changes.

Choose between a 4-week supply or a 12-week supply. Your selection represents the supply length you are requesting; approval, dosage, formulation, and treatment instructions are determined by the prescribing provider and dispensing pharmacy.

Your purchase includes a provider evaluation for consideration of compounded sublingual semaglutide. A licensed provider will review your medical history and questionnaire responses to determine whether treatment is appropriate. No laboratory work is required for initial consideration, although additional information or testing may be requested based on your individual health needs.

Sublingual semaglutide is a compounded formulation, and absorption and individual response may differ from injectable or FDA-approved semaglutide products. Use the medication only as directed, including instructions for placement under the tongue, timing, storage, and dosing.

Purchasing an evaluation does not guarantee approval, a prescription, or specific weight-loss results. Compounded sublingual semaglutide is not FDA-approved and is not reviewed by the FDA for safety, effectiveness, or quality before being marketed.